NCT02112916

Clinical Trial Information


Trial Number: NCT02112916 (ClinicalTrials.gov)
Disease Type:
  • Hematopoietic Neoplasm/Leukemia - Acute Lymphoblastic Leukemia
  • Hematopoietic Neoplasm/Lymphoma - Non-Hodgkin Lymphoma
Trial Title:
A Phase III Randomized Trial Investigating Bortezomib (NSC# 681239) on a Modified Augmented BFM (ABFM) Backbone in Newly Diagnosed T-Lymphoblastic Leukemia (T-ALL) and T-Lymphoblastic Lymphoma (T-LLy)
Study ID:
AALL1231
Images are available?:
No
Is this a NCI-MATCH Trial?:
No

Accessibility  |  Disclaimer  |  FOIA  |  HHS Vulnerability Disclosure  |  Privacy & Security

U.S. Department of Health and Human Services  |  National Institutes of Health  |  National Cancer Institute  |  USA.gov

NIH…Turning Discovery Into Health®